Global and China Rare Disease Genetic Testing Industry Ecological Development and Analysis Report 2023
In terms of market side, this report researches the Rare Disease Genetic Testing revenue, growth rate, market share by manufacturers, by type, by application and by region (region level and country level), from 2018 to 2023, and forecast to 2029.
The global Rare Disease Genetic Testing market size in 2022 is 882.1 million US dollars, and it is expected to be 1982.0 million US dollars by 2029, with a compound annual growth rate of 12.26% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Rare Disease Genetic Testing market include Quest Diagnostics Incorporated (U.S.), Centogene N.V. (Germany), Strand Life Sciences (Bengaluru), Ambry Genetics (U.S.), and PerkinElmer, Inc. (U.S.). The share of the top 3 players in the Rare Disease Genetic Testing market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Rare Disease Genetic Testing market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Neurological Disorders accounted for XX% of Rare Disease Genetic Testing market in 2022. Immunological Disorders share of XX%.
Research Laboratories accounted for XX% of the Rare Disease Genetic Testing market in 2022. CROs accounts for XX%.
Report Includes:
This report presents an overview of global market for Rare Disease Genetic Testing. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key players of Rare Disease Genetic Testing, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Rare Disease Genetic Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Rare Disease Genetic Testing market share and industry ranking of main players, data from 2018 to 2023. Identification of the major stakeholders in the global Rare Disease Genetic Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, from 2018 to 2029. Evaluation and forecast the market size for Rare Disease Genetic Testing sales, projected growth trends, technology, application and end-user industry.
Chapter Outline
Chapter 1: Introduces the product overview, research purposes, and then includes economic analysis of global regions, inflation analysis, and the impact of the Russian-Ukrainian war on the market.
Chapter 2: Analysis of the competitive environment of Rare Disease Genetic Testing market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapters 3-5: Segmented the global Rare Disease Genetic Testing market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapter 6: Analyzes the main companies in the Rare Disease Genetic Testing industry, including their main businesses, products/services, revenue, gross margin, and SWOT Analysis.
Chapter 7: Analyzes the Rare Disease Genetic Testing business cost, including industrial chain and the proportion of business cost structure.
Chapter 8: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapters 9-10: Provide detailed Rare Disease Genetic Testing market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 11: The main points and conclusions of the report.
Highlights-Regions
North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico
Player list
Quest Diagnostics Incorporated (U.S.)
Centogene N.V. (Germany)
Strand Life Sciences (Bengaluru)
Ambry Genetics (U.S.)
PerkinElmer, Inc. (U.S.)
Macrogen, Inc. (South Korea)
Baylor Genetics (U.S.)
HNL Lab Medicine (U.S.)
Preventiongenetics (U.S.)
3billion, Inc. (South Korea)
Arup Laboratories (U.S.)
HNL Lab Medicine (U.S.)
Preventiongenetics (U.S.)
Invitae Corporation (U.S.)
Eurofins Scientific (Luxembourg)
Strand Life Sciences (India)
Realm IDX, Inc. (China)
Myriad Genetics, Inc. (U.S.)
Laboratory Corporation of America Holdings (U.S.)
Opko Health, Inc. (U.S.)
Types list
Neurological Disorders
Immunological Disorders
Hematology Diseases
Endocrine
Metabolism Diseases
Cancer
Musculoskeletal Disorders
Cardiovascular Disorders (CVDs)
Dermatology Disease
Others
Application list
Research Laboratories
CROs
Diagnostic Centers
Hospitals
Clinics
Table of Content
1 Rare Disease Genetic Testing Market Introduction and Overview
1.1 Rare Disease Genetic Testing Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Rare Disease Genetic Testing Revenue and Market Share by Manufacturer
2.2 Manufacturers Rare Disease Genetic Testing Production Sites, Area Served, Product Types
2.3 Rare Disease Genetic Testing Market Competitive Situation and Trends
2.3.1 Rare Disease Genetic Testing Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.3.3 Mergers & Acquisitions, Expansion
3 Global Rare Disease Genetic Testing Historical Market Analysis by Type
3.1 Market Size Analysis by Types
3.1.4 Global Rare Disease Genetic Testing Market Share by Type 2018 VS 2022
3.2 Global Rare Disease Genetic Testing Revenue and Market Share by Type
4 Global Rare Disease Genetic Testing Historical and Forecast Market Analysis by Application
4.1 Market Size Analysis by Application
4.1.4 Global Rare Disease Genetic Testing Market Share by Application 2018 VS 2022
4.2 Global Rare Disease Genetic Testing Revenue Market Share by Application (2018-2023)
5 Global Market Growth Trends Analysis
5.1 Global Rare Disease Genetic Testing Market Size (2018-2023)
5.2 Rare Disease Genetic Testing Growth Trends Analysis by Regions
5.2.1 Rare Disease Genetic Testing Market Size by Regions: 2018 VS 2023 VS 2029
5.2.2 Rare Disease Genetic Testing Historic Revenue Market Size by Regions (2018-2023)
5.3 North America
5.3.1 North America Rare Disease Genetic Testing Revenue by Countries (2018-2023)
5.3.2 North America SWOT Analysis
5.3.3 United States
5.3.4 Canada
5.4 China
5.4.1 China SWOT Analysis
5.5 Asia Pacific (Excluding China)
5.5.1 Asia Pacific Rare Disease Genetic Testing Revenue by Countries (2018-2023)
5.5.2 Asia Pacific SWOT Analysis
5.5.3 Japan
5.5.4 Korea
5.5.5 Southeast Asia
5.5.6 India
5.5.7 Australia
5.6 EMEA
5.6.1 EMEA Rare Disease Genetic Testing Revenue by Countries (2018-2023)
5.6.2 EMEA SWOT Analysis
5.6.3 Europe
5.6.4 Middle East
5.6.5 Africa
5.7 Latin America
5.7.1 Latin America Rare Disease Genetic Testing Revenue by Countries (2018-2023)
5.7.2 Latin America SWOT Analysis
5.7.3 Brazil
5.7.4 Argentina
5.7.5 Mexico
6 Players Profiles
6.1 Quest Diagnostics Incorporated (U.S.)
6.1.1 Quest Diagnostics Incorporated (U.S.) Company Profile
6.1.2 Rare Disease Genetic Testing Product Overview
6.1.3 Quest Diagnostics Incorporated (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.1.4 Quest Diagnostics Incorporated (U.S.) Business Overview
6.1.5 SWOT Analysis
6.2 Centogene N.V. (Germany)
6.2.1 Centogene N.V. (Germany) Company Profile
6.2.2 Rare Disease Genetic Testing Product Overview
6.2.3 Centogene N.V. (Germany) Rare Disease Genetic Testing Market Performance (2018-2023)
6.2.4 Centogene N.V. (Germany) Business Overview
6.2.5 SWOT Analysis
6.3 Strand Life Sciences (Bengaluru)
6.3.1 Strand Life Sciences (Bengaluru) Company Profile
6.3.2 Rare Disease Genetic Testing Product Overview
6.3.3 Strand Life Sciences (Bengaluru) Rare Disease Genetic Testing Market Performance (2018-2023)
6.3.4 Strand Life Sciences (Bengaluru) Business Overview
6.3.5 SWOT Analysis
6.4 Ambry Genetics (U.S.)
6.4.1 Ambry Genetics (U.S.) Company Profile
6.4.2 Rare Disease Genetic Testing Product Overview
6.4.3 Ambry Genetics (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.4.4 Ambry Genetics (U.S.) Business Overview
6.4.5 SWOT Analysis
6.5 PerkinElmer, Inc. (U.S.)
6.5.1 PerkinElmer, Inc. (U.S.) Company Profile
6.5.2 Rare Disease Genetic Testing Product Overview
6.5.3 PerkinElmer, Inc. (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.5.4 PerkinElmer, Inc. (U.S.) Business Overview
6.5.5 SWOT Analysis
6.6 Macrogen, Inc. (South Korea)
6.6.1 Macrogen, Inc. (South Korea) Company Profile
6.6.2 Rare Disease Genetic Testing Product Overview
6.6.3 Macrogen, Inc. (South Korea) Rare Disease Genetic Testing Market Performance (2018-2023)
6.6.4 Macrogen, Inc. (South Korea) Business Overview
6.6.5 SWOT Analysis
6.7 Baylor Genetics (U.S.)
6.7.1 Baylor Genetics (U.S.) Company Profile
6.7.2 Rare Disease Genetic Testing Product Overview
6.7.3 Baylor Genetics (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.7.4 Baylor Genetics (U.S.) Business Overview
6.7.5 SWOT Analysis
6.8 HNL Lab Medicine (U.S.)
6.8.1 HNL Lab Medicine (U.S.) Company Profile
6.8.2 Rare Disease Genetic Testing Product Overview
6.8.3 HNL Lab Medicine (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.8.4 HNL Lab Medicine (U.S.) Business Overview
6.8.5 SWOT Analysis
6.9 Preventiongenetics (U.S.)
6.9.1 Preventiongenetics (U.S.) Company Profile
6.9.2 Rare Disease Genetic Testing Product Overview
6.9.3 Preventiongenetics (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.9.4 Preventiongenetics (U.S.) Business Overview
6.9.5 SWOT Analysis
6.10 3billion, Inc. (South Korea)
6.10.1 3billion, Inc. (South Korea) Company Profile
6.10.2 Rare Disease Genetic Testing Product Overview
6.10.3 3billion, Inc. (South Korea) Rare Disease Genetic Testing Market Performance (2018-2023)
6.10.4 3billion, Inc. (South Korea) Business Overview
6.10.5 SWOT Analysis
6.11 Arup Laboratories (U.S.)
6.11.1 Arup Laboratories (U.S.) Company Profile
6.11.2 Rare Disease Genetic Testing Product Overview
6.11.3 Arup Laboratories (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.11.4 Arup Laboratories (U.S.) Business Overview
6.11.5 SWOT Analysis
6.12 HNL Lab Medicine (U.S.)
6.12.1 HNL Lab Medicine (U.S.) Company Profile
6.12.2 Rare Disease Genetic Testing Product Overview
6.12.3 HNL Lab Medicine (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.12.4 HNL Lab Medicine (U.S.) Business Overview
6.12.5 SWOT Analysis
6.13 Preventiongenetics (U.S.)
6.13.1 Preventiongenetics (U.S.) Company Profile
6.13.2 Rare Disease Genetic Testing Product Overview
6.13.3 Preventiongenetics (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.13.4 Preventiongenetics (U.S.) Business Overview
6.13.5 SWOT Analysis
6.14 Invitae Corporation (U.S.)
6.14.1 Invitae Corporation (U.S.) Company Profile
6.14.2 Rare Disease Genetic Testing Product Overview
6.14.3 Invitae Corporation (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.14.4 Invitae Corporation (U.S.) Business Overview
6.14.5 SWOT Analysis
6.15 Eurofins Scientific (Luxembourg)
6.15.1 Eurofins Scientific (Luxembourg) Company Profile
6.15.2 Rare Disease Genetic Testing Product Overview
6.15.3 Eurofins Scientific (Luxembourg) Rare Disease Genetic Testing Market Performance (2018-2023)
6.15.4 Eurofins Scientific (Luxembourg) Business Overview
6.15.5 SWOT Analysis
6.16 Strand Life Sciences (India)
6.16.1 Strand Life Sciences (India) Company Profile
6.16.2 Rare Disease Genetic Testing Product Overview
6.16.3 Strand Life Sciences (India) Rare Disease Genetic Testing Market Performance (2018-2023)
6.16.4 Strand Life Sciences (India) Business Overview
6.16.5 SWOT Analysis
6.17 Realm IDX, Inc. (China)
6.17.1 Realm IDX, Inc. (China) Company Profile
6.17.2 Rare Disease Genetic Testing Product Overview
6.17.3 Realm IDX, Inc. (China) Rare Disease Genetic Testing Market Performance (2018-2023)
6.17.4 Realm IDX, Inc. (China) Business Overview
6.17.5 SWOT Analysis
6.18 Myriad Genetics, Inc. (U.S.)
6.18.1 Myriad Genetics, Inc. (U.S.) Company Profile
6.18.2 Rare Disease Genetic Testing Product Overview
6.18.3 Myriad Genetics, Inc. (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.18.4 Myriad Genetics, Inc. (U.S.) Business Overview
6.18.5 SWOT Analysis
6.19 Laboratory Corporation of America Holdings (U.S.)
6.19.1 Laboratory Corporation of America Holdings (U.S.) Company Profile
6.19.2 Rare Disease Genetic Testing Product Overview
6.19.3 Laboratory Corporation of America Holdings (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.19.4 Laboratory Corporation of America Holdings (U.S.) Business Overview
6.19.5 SWOT Analysis
6.20 Opko Health, Inc. (U.S.)
6.20.1 Opko Health, Inc. (U.S.) Company Profile
6.20.2 Rare Disease Genetic Testing Product Overview
6.20.3 Opko Health, Inc. (U.S.) Rare Disease Genetic Testing Market Performance (2018-2023)
6.20.4 Opko Health, Inc. (U.S.) Business Overview
6.20.5 SWOT Analysis
7 Rare Disease Genetic Testing Business Cost Analysis
7.1 Labor Cost Analysis
7.2 Proportion of Manufacturing Cost Structure
7.3 Rare Disease Genetic Testing Industrial Chain Analysis
8 Rare Disease Genetic Testing Industry Dynamic Analysis
8.1 Rare Disease Genetic Testing Market Trends Analysis
8.2 Rare Disease Genetic Testing Market Drivers Analysis
8.3 Rare Disease Genetic Testing Market Challenges Analysis
8.4 Rare Disease Genetic Testing Market Restraints Analysis
9 Global Rare Disease Genetic Testing Forecast Market Analysis by Type & Application
9.1 Global Rare Disease Genetic Testing Revenue Market Forecast by Type (2023-2029)
9.2 Rare Disease Genetic Testing Revenue Market Forecast by Application (2023-2029)
10 Global Rare Disease Genetic Testing Forecast Market Analysis by Region
10.1 Rare Disease Genetic Testing Revenue Market Forecast by Region (2023-2029)
10.2 North America Rare Disease Genetic Testing Forecast Market Analysis
10.3 EMEA Rare Disease Genetic Testing Forecast Market Analysis
10.4 China Rare Disease Genetic Testing Forecast Market Analysis
10.5 Asia-Pacific Rare Disease Genetic Testing Forecast Market Analysis
10.6 Latin America Rare Disease Genetic Testing Forecast Market Analysis
11 Research Findings and Conclusion
List of Tables and Figures
Figure Rare Disease Genetic Testing Picture
Table Product Definition of Rare Disease Genetic Testing
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Table Global Rare Disease Genetic Testing Revenue ($) by Manufacturer (2018-2023)
Table Global Rare Disease Genetic Testing Revenue Market Share by Manufacturer (2018-2023)
Figure Global Rare Disease Genetic Testing Revenue Market Share by Manufacturer in 2023
Table Manufacturers Rare Disease Genetic Testing Production Sites, Area Served, Product Types
Table Rare Disease Genetic Testing Market Concentration Rate
Figure Global Top 5 and Top 10 Players Market Share by Revenue in 2023
Table Mergers & Acquisitions, Expansion Plans
Table Global Rare Disease Genetic Testing Market Size by Type (2023 VS 2029)
Figure Global Rare Disease Genetic Testing Market Share by Type 2018 VS 2022
Table Global Rare Disease Genetic Testing Revenue and Market Size by Type (2018-2023)
Table Global Rare Disease Genetic Testing Revenue and Market Share by Type (2018-2023)
Table Global Rare Disease Genetic Testing Market Size by Application (2023 VS 2029)
Figure Global Rare Disease Genetic Testing Market Share by Application 2018 VS 2022
Table Global Rare Disease Genetic Testing Revenue Market Size by Application (2018-2023)
Table Global Rare Disease Genetic Testing Revenue Market Share by Application (2018-2023)
Figure Global Rare Disease Genetic Testing Revenue Market Size (2018-2023)
Table Rare Disease Genetic Testing Market Size by Regions: 2018 VS 2023 VS 2029
Table Rare Disease Genetic Testing Historic Revenue Market Size by Regions (2018-2023)
Table Rare Disease Genetic Testing Historic Revenue Market Share by Regions (2018-2023)
Figure North America Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Table North America Rare Disease Genetic Testing Revenue by Countries (2018-2023)
Table North America Rare Disease Genetic Testing Revenue Market Share by Countries (2018-2023)
Table North America SWOT Analysis
Figure United States Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Canada Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Table China SWOT Analysis
Figure China Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Asia Pacific Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Table Asia-Pacific Rare Disease Genetic Testing Revenue by Countries (2018-2023)
Table Asia-Pacific Rare Disease Genetic Testing Revenue Market Share by Countries (2018-2023)
Table Asia Pacific SWOT Analysis
Figure Japan Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Korea Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Southeast Asia Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure India Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Australia Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure EMEA Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Table EMEA Rare Disease Genetic Testing Revenue by Countries (2018-2023)
Table EMEA Rare Disease Genetic Testing Revenue Market Share by Countries (2018-2023)
Table EMEA SWOT Analysis
Figure Europe Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Germany Rare Disease Genetic Testing Revenue and Growth (2018-2029)
Figure France Rare Disease Genetic Testing Revenue and Growth (2018-2029)
Figure UK Rare Disease Genetic Testing Revenue and Growth (2018-2029)
Figure Italy Rare Disease Genetic Testing Revenue and Growth (2018-2029)
Figure Russia Rare Disease Genetic Testing Revenue and Growth (2018-2029)
Figure Nordic Rare Disease Genetic Testing Revenue and Growth (2018-2029)
Figure Middle East Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Africa Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Latin America Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Table Latin America Rare Disease Genetic Testing Revenue by Countries (2018-2023)
Table Latin America Rare Disease Genetic Testing Revenue Market Share by Countries (2018-2023)
Table Latin America SWOT Analysis
Figure Brazil Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Argentina Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Figure Mexico Rare Disease Genetic Testing Revenue and Growth (2018-2023)
Table Quest Diagnostics Incorporated (U.S.) Profile
Table Product Overview
Table Quest Diagnostics Incorporated (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Quest Diagnostics Incorporated (U.S.) Revenue and Growth Rate
Figure Quest Diagnostics Incorporated (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Centogene N.V. (Germany) Profile
Table Product Overview
Table Centogene N.V. (Germany) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Centogene N.V. (Germany) Revenue and Growth Rate
Figure Centogene N.V. (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Strand Life Sciences (Bengaluru) Profile
Table Product Overview
Table Strand Life Sciences (Bengaluru) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Strand Life Sciences (Bengaluru) Revenue and Growth Rate
Figure Strand Life Sciences (Bengaluru) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Ambry Genetics (U.S.) Profile
Table Product Overview
Table Ambry Genetics (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Ambry Genetics (U.S.) Revenue and Growth Rate
Figure Ambry Genetics (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table PerkinElmer, Inc. (U.S.) Profile
Table Product Overview
Table PerkinElmer, Inc. (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure PerkinElmer, Inc. (U.S.) Revenue and Growth Rate
Figure PerkinElmer, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Macrogen, Inc. (South Korea) Profile
Table Product Overview
Table Macrogen, Inc. (South Korea) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Macrogen, Inc. (South Korea) Revenue and Growth Rate
Figure Macrogen, Inc. (South Korea) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Baylor Genetics (U.S.) Profile
Table Product Overview
Table Baylor Genetics (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Baylor Genetics (U.S.) Revenue and Growth Rate
Figure Baylor Genetics (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table HNL Lab Medicine (U.S.) Profile
Table Product Overview
Table HNL Lab Medicine (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure HNL Lab Medicine (U.S.) Revenue and Growth Rate
Figure HNL Lab Medicine (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Preventiongenetics (U.S.) Profile
Table Product Overview
Table Preventiongenetics (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Preventiongenetics (U.S.) Revenue and Growth Rate
Figure Preventiongenetics (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table 3billion, Inc. (South Korea) Profile
Table Product Overview
Table 3billion, Inc. (South Korea) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure 3billion, Inc. (South Korea) Revenue and Growth Rate
Figure 3billion, Inc. (South Korea) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Arup Laboratories (U.S.) Profile
Table Product Overview
Table Arup Laboratories (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Arup Laboratories (U.S.) Revenue and Growth Rate
Figure Arup Laboratories (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table HNL Lab Medicine (U.S.) Profile
Table Product Overview
Table HNL Lab Medicine (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure HNL Lab Medicine (U.S.) Revenue and Growth Rate
Figure HNL Lab Medicine (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Preventiongenetics (U.S.) Profile
Table Product Overview
Table Preventiongenetics (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Preventiongenetics (U.S.) Revenue and Growth Rate
Figure Preventiongenetics (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Invitae Corporation (U.S.) Profile
Table Product Overview
Table Invitae Corporation (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Invitae Corporation (U.S.) Revenue and Growth Rate
Figure Invitae Corporation (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Eurofins Scientific (Luxembourg) Profile
Table Product Overview
Table Eurofins Scientific (Luxembourg) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Eurofins Scientific (Luxembourg) Revenue and Growth Rate
Figure Eurofins Scientific (Luxembourg) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Strand Life Sciences (India) Profile
Table Product Overview
Table Strand Life Sciences (India) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Strand Life Sciences (India) Revenue and Growth Rate
Figure Strand Life Sciences (India) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Realm IDX, Inc. (China) Profile
Table Product Overview
Table Realm IDX, Inc. (China) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Realm IDX, Inc. (China) Revenue and Growth Rate
Figure Realm IDX, Inc. (China) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Myriad Genetics, Inc. (U.S.) Profile
Table Product Overview
Table Myriad Genetics, Inc. (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Myriad Genetics, Inc. (U.S.) Revenue and Growth Rate
Figure Myriad Genetics, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Laboratory Corporation of America Holdings (U.S.) Profile
Table Product Overview
Table Laboratory Corporation of America Holdings (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Laboratory Corporation of America Holdings (U.S.) Revenue and Growth Rate
Figure Laboratory Corporation of America Holdings (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Opko Health, Inc. (U.S.) Profile
Table Product Overview
Table Opko Health, Inc. (U.S.) Rare Disease Genetic Testing Revenue, Gross and Gross Margin (2018-2023)
Figure Opko Health, Inc. (U.S.) Revenue and Growth Rate
Figure Opko Health, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Labor Cost Analysis
Figure Proportion of Manufacturing Cost Structure
Figure Rare Disease Genetic Testing Industrial Chain Analysis
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Global Rare Disease Genetic Testing Revenue Market Size Forecast by Type (2023-2029)
Table Global Rare Disease Genetic Testing Revenue Market Share Forecast by Type (2023-2029)
Table Global Rare Disease Genetic Testing Revenue Market Size by Application (2023-2029)
Table Global Rare Disease Genetic Testing Revenue Market Share by Application (2023-2029)
Table Global Rare Disease Genetic Testing Revenue Market Size by Region (2023-2029)
Table Global Rare Disease Genetic Testing Revenue Market Share by Region (2023-2029)
Figure North America Rare Disease Genetic Testing Forecast Revenue and Growth 2023-2029
Figure EMEA Rare Disease Genetic Testing Forecast Revenue and Growth 2023-2029
Figure China Rare Disease Genetic Testing Forecast Revenue and Growth 2023-2029
Figure Asia-Pacific Rare Disease Genetic Testing Forecast Revenue and Growth 2023-2029
Figure Latin America Rare Disease Genetic Testing Forecast Revenue and Growth 2023-2029
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|